Remlifanserin (ACP-204) is a highly selective 5-HT2A inverse agonist. Remlifanserin is applicable to research related to Alzheimer's disease psychosis [1].
In Vitro, Remlifanserin modulates symptoms of AD and indirectly alleviates neuroinflammation and oxidative stress responses[1].
References:
[1]. Gurikar S, et al. Targeting Oligodendrocyte Dysfunction in Alzheimer's Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists. J Mol Neurosci. 2025;75(4):139. Published 2025 Oct 15.
In Vitro, Remlifanserin modulates symptoms of AD and indirectly alleviates neuroinflammation and oxidative stress responses[1].
References:
[1]. Gurikar S, et al. Targeting Oligodendrocyte Dysfunction in Alzheimer's Disease: a New Frontier for Drug Repurposing with Antihistamines and Serotonin Receptor Agonists. J Mol Neurosci. 2025;75(4):139. Published 2025 Oct 15.